Clinical Trial Update: [18F] PSMA-1007 PET/CT in Metastatic Clear Cell Renal Cell Carcinoma [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial evaluating [18F] PSMA-1007 PET/CT for detecting metastatic renal cell carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma Clear Cell Metastatic

Drugs mentioned

• 18F-PSMA-1007 (PSMA-1007 radiotracer)

Snippet

Sponsor: Western University | Conditions: Metastatic Clear Cell Renal Cell Carcinoma | EARLY_Phase 1 | Status: RECRUITING